DNA Day Illinois 2013 Webinar: Newborn Screening and Family Health History. Tuesday, April 16, 2013
|
|
- Aldous Walsh
- 5 years ago
- Views:
Transcription
1 DNA Day Illinois 2013 Webinar: Newborn Screening and Family Health History Tuesday, April 16, 2013
2 Objectives Recognize the importance & impact of newborn screening Describe the process of newborn screening Identify disorders being screened for and new disorders being added to newborn screening in Illinois Identify connection between family health history and newborn screening Recognize how disorders and health risks are inherited Outline benefits to gathering family health history Illustrate importance of family health history and newborn screening
3 Acknowledgments
4 Place of employment Poll What type of health center do you work in? a) Local public health department b) State public health department c) Hospital d) Federally Qualified Health Center e) Private Practice f) Other
5 Job position poll What is your job position? a) Nurse b) Doctor c) Genetic Counselor d) Social Worker e) Other health related position f) Other non health related position
6 Presenters Michelle Gilats Marie Vonesh
7 Newborn Screening
8 History and Impact Approximate No. of Newborns in IL Annually Screened Diagnosed 165,
9 Introduction to Genetics Genes are like the body s blueprints Some mutations lead to different traits Other mutations alter function of protein and lead to disease
10 Newborn Screening Process What: A blood test performed by heel stick Screening also includes a hearing test and can include pulse oximetry When: hours after birth Where: In hospital Why: To determine if a baby has a serious medical condition that needs early intervention
11 Screening in Illinois Screening differs from state to state IL currently screens for 29 core conditions IL is adding 7 Lyosomal Storage Disorders and Severe Combined Immunodeficiency Disorder to its newborn screening panel
12 Lyosomal Disorders Fabry Gaucher Krabbe MPS I MPS II Niemann-Pick Pompe
13 Fabry Disease NBS measures: alpha-galactosidase Symptoms/Signs Treatment Pain Gastrointestinal Issues Possible stroke Renal damage Cardiomyopathy Enzyme replacement therapy Medications to treat existing symptoms
14 Gaucher Disease NBS measures: β - glucosylceramidase Symptoms/Signs Treatment Type I Bone disease Anemia Enlarged spleen Lung disease Type II Neurological disease Enzyme replacement therapy Substrate reduction therapy Bone Marrow Transplant
15 Krabbe Disease NBS measures: galactocerebrosidase Symptoms/Signs Treatment Infantile Type Irritability Hypertonicity Progressive neurologic deterioration Late Onset Forms Weakness Vision Loss Intellectual regression Supportive care Stem cell transplant
16 Mucopolysaccharidosis Type I (MPS I) NBS measures: alpha-l-iduronidase Symptoms/Signs Treatment Severe Type Coarse facial features Enlarged liver and spleen Skeletal abnormalities Hearing loss Corneal clouding Intellectual disability Attenuated Type Severity and rate of progression varies Enzyme replacement therapy Stem cell transplant
17 Mucopolysaccharidosis Type II (MPS II) NBS measures: Iduronate-2-sulfatase Symptoms/Signs Treatment Enlarged liver and spleen Skeletal abnormalities Severe Type Progressive cognitive deterioration Progressive airway disease Cardiac disease Chronic diarrhea Attenuated Type No CNS involvement Enzyme replacement therapy
18 Niemann-Pick Disease NBS measures: Acid sphingomyelinase Symptoms/Signs Treatment Type A Enlarged liver and spleen Cherry red spot in retina Recurrent respiratory infections Neurological deterioration Type B No neurological involvement Enlarged liver and spleen Pulmonary function deterioration Supportive care
19 Symptoms/Signs Infantile Onset Hypotonia Muscle weakness Cardiomegaly & hypertrophic cardiomyopathy Feeding difficulties Failure to thrive Respiratory distress Hearing loss Late Onset Proximal muscle weakness Respiratory insufficiency without cardiac involvement Pompe Disease NBS measures: alpha-glucosidase Treatment Enzyme replacement therapy Physical therapy Respiratory support
20 SCID and CCHD Severe Combined Immunodeficiency (SCID) Known as Bubble Boy disease Inheritance: Autosomal recessive or X-linked Group of disorders that lead to absence of T- lymphocytes Symptoms: Recurrent infections, death within 1 year if not treated Treatment: Stem cell transplant (within first 3 months of life), bone marrow transplant, immunoglobulin injections, prophylactic antibiotics Critical Congenital Heart Disease (CCHD) ~15% due to genetic causes Group of defects that typically require treatment within first year of life Symptoms: Cyanosis, breathing difficulty, poor weight gain Treatment: Possible surgery, medications, catheterization NBS measure: Pulse oximetry (not a blood test) NBS measure: Lymphocytes
21 Limitations Additional testing needed Importance of genetic counseling Consumer education important
22 Family Health History
23 Types of inheritance Autosomal Recessive
24 Types of inheritance Autosomal Dominant
25 Types of inheritance X-Linked
26 Living with Fabry Disease
27 Discovery Gynecologist Primary Doctor Nephrologist Biopsy Screening DNA Testing December 2002 January May2003 June 2003 June 2003
28 Symptoms Sweating Heat & Cold Intolerance Skin Issues Eye Issues High Fevers Stomach Issues Hearing Loss Kidney Problems Heart Atrial Fibrillation
29 Treatment October 2003 Hospitals Centers Home
30 Family Health History Grandparents Male Female Not Affected by Fabry Disease John Yanoula Affected by Fabry Disease Uncles Deceased Parents Gus Sam Peggy Chris George Bill Harry Siblings Martha Joanne Marie Me
31 Family Health History Siblings Martha Joanne Me Jessica Rebecca Brandon Ryan Ian Sophia Ella Quinn Gavin
32 Effects on Family
33 Newborn Screening
34 Questions
35 Resources Illinois Department of Public Health Genetics Program: Genetic Education for Illinois: Newborn Screening in Illinois: Newborn Screening for Practitioners: Family Health History: National Fabry Disease Foundation
36 References American College of Medical Genetics and Genomics. (2012). Newborn screening ACT sheets and confirmatory algorithms. Retrieved October 11, 2012 from acmg.net/am/template.cfm?section=nbs_act_sheets_and_algorithms_table& Template=/CM/HTMLDisplay.cfm&ContentID=5072 Baby s First Test. (2012). Homepage. Retrieved January 24, 2013 from test.org/ Burke, S. & Kirk, M. (2006). Genetics education in the nursing profession: Literature review. Journal of Advanced Nursing, 54(2), Davis, T.C., Humiston, S.G., Arnold, C.L, Bocchini, J.A., Bass, P.F., Kennen, E.M.Lloyd- Puryear, M. (2006). Recommendations for effective newborn screening communication: Results of focus groups with parents, providers, and experts. Pediatrics, 117(5), S Genetic Alliance. (2009). Understanding genetics: A New York, Mid-Atlantic guide for patients and health professionals. Retrieved October 11, 2012 from resourcerepository.org/documents/1247/understandinggenetics:aneyyork,mid-atlantic guideforpatientsandhealthprofessionals Kemper, A.R., Fant, K.E. & Clark, S.J. (2005). Informing parents about newborn screening. Public Health Nursing, 22(4), Mehta, A. & Hughes, D. (2011). Fabry Disease. Retrieved October 29, 2012 from ncbi.nlm.nih.gov/books/nbk1292/ McCabe, L.L., Therrell, B.L., & McCabe, E.R. (2002). Newborn screening: Rationale for a comprehensive, fully integrated public health system. Molecular Genetics and Metabolism, 77, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention. (2012). Pulse oximetry screening for critical congenital heart defects. Retrieved January 17, 2013 from
37 References National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention. (2013). Newborn screening. Retrieved January 24, 2012 from National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention. (2013). Screening for critical congenital heart defects. Retrieved January 24, 2013 from National Fabry Disease Foundation. (2012). Fabry disease symptoms overview. Retrieved March 12, 2013, from symptoms-overview National Institute of Neurological Disorders and Stroke, National Institutes of Health. (2011). NINDS Gaucher Disease information page. Retrieved October 29, 2012 from National Institute of Neurological Disorders and Stroke, National Institutes of Health. (2011). NINDS Krabbe Disease information page. Retrieved October 29, 2012 from National Society of Genetic Counselors. (n.d.). Your family history. Retrieved January 24, 2013 from U.S. Department of Health and Human Services. (n.d.). My family health portrait: A tool from the Surgeon General. Retrieved January 24, 2013 from fhh-web/popup/gethelp/helpdetailslearnmore.action#users U.S. National Library of Medicine, National Institutes of Health. (2013). Inheriting genetic conditions: Inheritance patterns and understanding risk. Retrieved October 11, 2011 from
What s New in Newborn Screening?
What s New in Newborn Screening? Funded by: Illinois Department of Public Health Information on Newborn Screening Newborn screening in Illinois is administered by the Illinois Department of Public Health.
More informationWhat s New in Newborn Screening?
What s New in Newborn Screening? Funded by: Illinois Department of Public Health Information on Newborn Screening Newborn screening in Illinois is mandated and administered by the Illinois Department of
More informationNewborn Screening for Lysosomal Storage Diseases in Missouri. Outline
Newborn Screening for Lysosomal Storage Diseases in Missouri Dr. Kathy Grange Division of Genetics and Genomic Medicine Department of Pediatrics Washington University Outline Brief overview of clinical
More informationA Lawyer s Perspective on Genetic Screening Performed by Cryobanks
A Lawyer s Perspective on Genetic Screening Performed by Cryobanks As a lawyer practicing in the area of sperm bank litigation, I have, unfortunately, represented too many couples that conceived a child
More informationDEVELOPING A FOLLOW-UP FRAMEWORK FOR POMPE DISEASE
DEVELOPING A FOLLOW-UP FRAMEWORK FOR POMPE DISEASE Presenter: Sarah Bradley, MS, CGC Genetic Counselor, NYS Newborn Screening Program Authors: S. Bradley, D. Kronn, B. Vogel, M. Caggana, J. Orsini, K.
More informationNeonatal manifestations of lysosomal storage diseases
Neonatal manifestations of lysosomal storage diseases Nadia ALhashmi MD Metabolic &genetic disorder Royal hospital 2 nd Oman international pediatric and neonatal conference 13 th -15 th April 2017 Muscat
More informationNewborn screening for congenital metabolic diseases Optional out-of-pocket tests Information Sheet
Newborn screening for congenital metabolic diseases Optional out-of-pocket tests Information Sheet Website:www.tipn.org.tw Telephone:(02)85962050 Ext. 401-403 Service line:(02)85962065 Fax:(02)85962067
More informationThe role of the laboratory in diagnosing lysosomal disorders
The role of the laboratory in diagnosing lysosomal disorders Dr Guy Besley, formerly Willink Biochemical Genetics Unit, Manchester Children s Hospital, Manchester M27 4HA, UK. Lysosomal disorders What
More informationDate of commencement: February Principal Investigator Dr. Jayesh J. Sheth CASE RECORD FORM
ICMR-FRIGE-MULTICENTRIC LSDs Project Foundation for Research in Genetics & Endocrinology [FRIGE], FRIGE House, Jodhpur Gam road, Satellite, Ahmedabad-380015 Tel no: 079-26921414, Fax no: 079-26921415 E-mail:
More informationPompe. Lysosomal Disorders. Introduction
Introduction disease is an inherited, genetic disorder which results in the lack of an enzyme 'acid alpha-glucosidase. disease is also known as acid maltase deficiency or glycogen storage disease type
More informationDisorder name: Severe Combined Immunodeficiency Acronym: SCID
Genetic Fact Sheets for Parents Other Disorders Screening, Technology, and Research in Genetics is a multi-state project to improve information about the financial, ethical, legal, and social issues surrounding
More informationInborn Error Of Metabolism :
Inborn Error Of Metabolism : Inborn Error Of Metabolism inborn error of metabolism are a large group of hereditary biochemical diseases in which specific gene mutation cause abnormal or missing proteins
More informationClinical Approach to Diagnosis of Lysosomal Storage Diseases
Clinical Approach to Diagnosis of Lysosomal Storage Diseases M. Rohrbach, MD, PhD FMH Pädiatrie und FMH Medizinische Genetik Abteilung Stoffwechsel Universitätskinderklinik Zürich Lysosomal storage disorders
More informationFatty Acids Synthesis L3
Fatty Acids Synthesis L3 The pathway for fatty acid synthesis occurs in the cytoplasm, whereas, oxidation occurs in the mitochondria. The other major difference is the use of nucleotide co-factors. Oxidation
More informationCurrent Newborn Screening Practices Across the Globe: Can We Standardize?
Current Newborn Screening Practices Across the Globe: Can We Standardize? International Society for Newborn Screening European Regional Conference Budapest November 5-6, 2012 R. Rodney Howell, M. D. Miller
More informationUnderstanding Late-Onset Pompe Disease
Understanding Late-Onset Pompe Disease What Is a Lysosome? Millions of tiny units called cells make up the human body. Each cell has its own job to keep the body running. Within each cell, there are organelles,
More informationPompe Disease. Family Education Booklet. Division of Pediatric Genetics Metabolism and Genomic Medicine
Pompe Disease Family Education Booklet Division of Pediatric Genetics Metabolism and Genomic Medicine Table of Contents What is Pompe disease?... 1 How common is Pompe disease?... 1 Basic genetic concepts...
More informationS2 Protein augmentation therapies for inherited disorders 1
Disease category Disorder S2 Protein augmentation therapies for inherited 1 Augmented protein 2 Source of therapeutic protein / peptide Outcome References 3 Membrane transport Coagulation Cystic fibrosis
More informationGENETICS 101. An overview of human genetics and practical applications from an adult medical genetics clinic
GENETICS 101 An overview of human genetics and practical applications from an adult medical genetics clinic Historical timeline of genetics Discuss basics of genetics Discuss tools used in clinic Discuss
More information1. Diagnosis of Lysosomal Storage Disorders in Australia. 2. Comparison of Incidence/prevalence of lysosomal storage diseases in different country
List of Tables: 1. Diagnosis of Lysosomal Storage Disorders in Australia 2. Comparison of Incidence/prevalence of lysosomal storage diseases in different country 3. Relative frequency of LSD in Portugal
More informationChapter 26. Newborn Screening
Chapter 26 Newborn Screening Severe Combined Immune Deficiency (SCID) leads to life-threatening infections unless the immune system can be restored through a bone marrow transplant, enzyme replacement
More informationINTRODUCTION. 1.
KRABBE DISEASE INTRODUCTION Krabbe disease is a genetic defect that affects the nervous system. It is caused by the shortage (deficiency) of an enzyme called galactosylceramidase. This enzyme deficiency
More informationHYPER IgM SYNDROME This booklet is intended for use by patients and their families and should not replace advice from a clinical immunologist.
HYPER IgM SYNDROME This booklet is intended for use by patients and their families and should not replace advice from a clinical immunologist. 1 HYPER IgM SYNDROME Also available : COMMON VARIABLE IMMUNODEFICIENCY
More informationNewborn Screening and Studies of Lysosomal Storage Diseases in CFOH
Newborn Screening and Studies of Lysosomal Storage Diseases in CFOH Chinese Foundation of Health National Yang-Ming University Director: Dr. Chuan-Chi Chiang Speaker: Hsuan-Chieh Liao (Joyce) 1 Newborn
More informationGenetic Testing FOR DISEASES OF INCREASED FREQUENCY IN THE ASHKENAZI JEWISH POPULATION
Carrier Screening and Diagnostic Testing for the Ashkenazi Jewish Population Genetic Testing FOR DISEASES OF INCREASED FREQUENCY IN THE ASHKENAZI JEWISH POPULATION Our Science. Your Care. An extensive
More informationNeonatal Screening for Lysosomal Storage Disorders (LSD) by Tandem Mass Spectrometry (MSMS)
Neonatal Screening for Lysosomal Storage isorders (LS) by Tandem Mass Spectrometry (MSMS) Enzo Ranieri and Samantha Stark 1 Head, Neonatal Screening Centre & Biochemical Genetics (G&MP) irectorate of Genetics
More informationPulse Oximetry Screening in Newborns to Enhance the Detection Of Critical Congenital Heart Disease. Frequently Asked Questions
Pulse Oximetry Screening in Newborns to Enhance the Detection Of Critical Congenital Heart Disease Frequently Asked Questions Current Recommendation: The current recommendation from the Canadian Cardiovascular
More informationChapter 11. Hyper IgM Syndromes
Chapter 11 Hyper IgM Syndromes Patients with Hyper-IgM (HIGM) syndrome are susceptible to recurrent and severe infections and in some types of HIGM syndrome opportunistic infections and an increased risk
More informationHeart disease. Other symptoms too? FABRY DISEASE IN PATIENTS WITH UNEXPLAINED HEART CONDITIONS
Heart disease Other symptoms too? FABRY DISEASE IN PATIENTS WITH UNEXPLAINED HEART CONDITIONS You have been given this brochure because your heart condition may be linked to Fabry disease, which is a rare,
More informationPATIENT EDUCATION. carrier screening INFORMATION
PATIENT EDUCATION carrier screening INFORMATION carrier screening AT A GLANCE Why is carrier screening recommended? Carrier screening is one of many tests that can help provide information to you and your
More informationSpinal Muscular Atrophy Newborn Screening
10.2018 Spinal Muscular Atrophy Newborn Screening Melissa Gibbons, MS, CGC Erica Wright, MS, CGC Clinical Genetics and Metabolism Department of Pediatrics Children s Hospital Colorado/ University of Colorado
More informationSevere Combined Immune Deficiency (SCID) A Guide for Parents Following a Diagnosis
Severe Combined Immune Deficiency (SCID) A Guide for Parents Following a Diagnosis Copyright 2014 by Immune Deficiency Foundation This translation was created by an entity other than IDF. As such, while
More informationFatty Acid Oxidation Disorders
Genetic Fact Sheets for Parents Fatty Acid Oxidation Disorders Screening, Technology, and Research in Genetics is a multi-state project to improve information about the financial, ethical, legal, and social
More informationAmy Powers. be absent) Amy Hietala. Tony Steyermark
Newborn Screening Advisory Committee Meeting Meeting Minutes of Tuesday, April 21, 2015 1:30-4:30 Wilder Center Auditorium A and B 451 Lexington Parkway North Saint Paul, MN 55104 Committee Members Present:
More informationScreening for Critical Congenital Heart Disease
Screening for Critical Congenital Heart Disease Caroline K. Lee, MD Pediatric Cardiology Disclosures I have no relevant financial relationships or conflicts of interest 1 Most Common Birth Defect Most
More informationLipid storage diseases
Lipid storage diseases What are lipid storage diseases? Lipid storage diseases, or the lipidoses, are a group of inherited metabolic disorders in which harmful amounts of fatty materials called lipids
More informationStuart Nicholls & Kevin Southern
Stuart Nicholls & Kevin Southern Nothing to declare If we want to better understand parental decision making we need to consider the context in which screening is provided. Background: Screening in the
More informationMetabolic Liver Disease
Metabolic Liver Disease Peter Eichenseer, MD No relationships to disclose. Outline Overview Alpha-1 antitrypsin deficiency Wilson s disease Hereditary hemochromatosis Pathophysiology Clinical features
More informationMEDICAL HISTORY. Previous Nephrologist. Medication taken Insulin Oral Both. Who manages your diabetes? Blindness Yes No Hearing Problems Yes No
MEDICAL HISTORY Please mark YES or NO and fill in appropriate blanks as needed Chronic Yes No If yes, year diagnosed Previous Nephrologist Transplant Yes No If yes, date Donor type Living Deceased Related
More informationMETABOLISM OF ACYLGLYCEROLS AND SPHINGOLIPDS. Ben S. Ashok MSc.,FAGE.,PhD., Dept. of Biochemistry
METABOLISM OF ACYLGLYCEROLS AND SPHINGOLIPDS Ben S. Ashok MSc.,FAGE.,PhD., Dept. of Biochemistry STORAGE AND MEMBRANE LIPIDS STORAGE LIPIDS Mainly as triacylglycerols (triglycerides) in adipose cells Constitute
More informationICHTHYOSIS. What are the aims of this leaflet?
ICHTHYOSIS What are the aims of this leaflet? This leaflet has been written to help you understand more about ichthyosis. It will tell you what it is, the types of ichthyosis, what can be done about it,
More informationA PARENT S POCKET GUIDE
A PARENT S POCKET GUIDE Newborn Screening is for ALL babies! Newborn screening finds specific health problems where early treatment can make a difference for your baby s future. Every baby born in Tennessee
More informationINBORN ERRORS OF METABOLISM (IEM) IAP UG Teaching slides
INBORN ERRORS OF METABOLISM (IEM) 1 OBJECTIVES What are IEMs? Categories When to suspect? History and clinical pointers Metabolic presentation Differential diagnosis Emergency and long term management
More information11/27/2012. Objectives. What is Critical Congenital Heart Disease?
Screening for Critical Congenital Heart Disease in the Apparently Healthy Newborn A presentation of Texas Pulse Oximetry Project: A Joint Educational Initiative of The University of Texas Health Science
More informationWhat to Expect at Seattle Children s Hospital
Patient and Family Education Heart Failure What to Expect at Seattle Children s Hospital This booklet is meant to help you understand heart failure and the care your child receives in the heart failure
More informationCell Phone #: Home Phone #: ** Address (prefer your forever address):
NEW PATIENT QUESTIONNAIRE * Some of this information is required by the CMS (Centers for Medicare and Medicaid Services). Your demographic answers will never affect your care. Today s Date: **Date of Birth:
More informationTEST INFORMATION Test: CarrierMap GEN (Genotyping) Panel: CarrierMap Expanded Diseases Tested: 311 Genes Tested: 299 Mutations Tested: 2647
Ordering Practice Jane Smith John Smith Practice Code: 675 Miller MD 374 Broadway New York, NY 10000 Physician: Dr. Frank Miller Report Generated: 2016-02-03 DOB: 1973-02-19 Gender: Female Ethnicity: European
More informationFatty Acid Oxidation Disorders
Genetic Fact Sheets for Parents Fatty Acid Oxidation Disorders Screening, Technology, and Research in Genetics is a multi-state project to improve information about the financial, ethical, legal, and social
More informationSialic Acid Storage Diseases
Sialic Acid Storage Diseases Class: BIOL 10001 Instructor: Dr. Vivegananthan Submitted by: Lyndsay Grover Date Submitted: Thursday March 24 th, 2011 Introduction to Sialic Acid Storage Diseases Sialic
More informationBest Practice Guidelines for the Biochemical Investigation of Patients with Foetal and Neonatal Hydrops
National Metabolic Biochemistry Network Best Practice Guidelines for the Biochemical Investigation of Patients with Foetal and Neonatal Hydrops INTRODUCTION Hydrops is defined as the presence of skin oedema
More informationInheritance of Gaucher Disease
Sarah Mother of a child with Gaucher Working toward a healthy future Helping her son achieve his own dreams, too Straight Talk For Patients and Families Inheritance of Gaucher Disease Genzyme Corporation
More information725 Jesse Jewell Pkwy, Suite 390 Gainesville, GA (770) (770) (facsimile)
Charles Nash, III, M.D., F.A.C.P. Richard J. LoCicero, M.D. Anup K. Lahiry, M.D. Timothy M. Carey, M.D. Andrew Johnson, M.D. 725 Jesse Jewell Pkwy, Suite 390 Gainesville, GA 30501 (770) 297-5700 (770)
More informationLSD WORKSHOP WHAT EVERY PEDIATRICIAN SHOULD KNOW. Amal Al Tenaiji Pediatric Metabolic Genetics SKMC Abu Dhabi
LSD WORKSHOP WHAT EVERY PEDIATRICIAN SHOULD KNOW Amal Al Tenaiji Pediatric Metabolic Genetics SKMC Abu Dhabi CASE A 1 month old infant presents with difficulty feeding and respiratory distress. Mom and
More informationBEHAVIOR & ADHD SCREENING INTAKE FORM
3171 N.E. Carnegie Drive, Suite A Lee s Summit, MO 64064 P: (816) 525-2800 F: (816) 525-4077 www.summitdoctors.com BEHAVIOR & ADHD SCREENING INTAKE FORM PATIENT NAME: TODAYS DATE / / LAST FIRST MI DATE
More informationEducation Brochure. Hereditary ATTR amyloidosis A closer look at an inherited condition
Education Brochure Hereditary ATTR amyloidosis A closer look at an inherited condition What is hereditary ATTR (hattr) amyloidosis? hattr amyloidosis is caused by a gene change (mutation) that affects
More informationGenetics Questions: There are 15 questions in total. The answers can be found on the accompanying document
Page 1 Genetics Questions: These questions are aimed at medical and allied health professionals and they are designed to show where genetics has a role in clinical practice. There are 15 questions in total
More information4) Thyroid Gland Defects - Dr. Tara
4) Thyroid Gland Defects - Dr. Tara Thyroid Pituitary Axis TRH secreted in the hypothalamus stimulates production and Secretion of TSH TSH stimulates secretion of T3, T4 T4 has negative feedback on secretion
More informationNew Waves of Newborn Screening: What's Next on the Horizon!
New Waves of Newborn Screening: What's Next on the Horizon! VIRGINIA AWHONN 2016 Emily. Drake PhD, RN, FAAN Special Thanks to: C. Cuthbert, A. Gaviglio, K. Olson Plan Introduction & Background Real-life
More informationMedical Specialists. SPECIALTY (type in contact name and phone number)
Medical Specialists SPECIALTY (type in contact name and phone number) Cardiothoracic Surgeon or Cardiovascular Surgeon Pediatric Cardiologist DESCRIPTION A physician specializing in surgical procedures
More informationThyroid gland defects. Dr. Tara Husain
Thyroid gland defects Dr. Tara Husain Thyroid Pituitary Axis TRH secreted in the hypothalamus stimulates production and Secretion of TSH TSH stimulates secretion of T3,T4 T4 has negative feed back on secretion
More informationStatus of Newborn Screening for Lysosomal Storage Disorders in Wisconsin
Status of Newborn Screening for Lysosomal Storage Disorders in Wisconsin Technical Workshop on Methods to Detect Pompe Disease and other Lysosomal Storage Disorders (LSDs) by Newborn Bloodspot Screening
More informationLysosomal Enzymes in fibroblasts
ERNDIM Administration Office Manchester Centre for Genomic Medicine 6 th Floor, St Mary's Hospital, Oxford Road, Manchester M13 9WL, United Kingdom. Tel: +44 161 276 6741 Fax: +44 161 850 1145 Email: admin@erndim.org
More informationHypoglycemia. Objectives. Glucose Metabolism
Hypoglycemia Instructor: Janet Mendis, MSN, RNC-NIC, CNS Outline: Janet Mendis, MSN, RNC-NIC, CNS Summer Morgan, MSN, RNC-NIC, CPNP UC San Diego Health System Objectives State the blood glucose level at
More informationTalking with Parents about a Positive Critical Congenital Heart Disease (CCHD) Screen or Test. Emily Drake, PhD RN May 20, 2014.
Talking with Parents about a Positive Critical Congenital Heart Disease (CCHD) Screen or Test Emily Drake, PhD RN May 20, 2014 Disclosure I have no financial or other conflicts of interest 1 Learning Objectives
More informationNewborn Screening. Helping babies start life healthy. Minnesota Newborn Screening Program
Newborn Screening Helping babies start life healthy Minnesota Newborn Screening Program What is newborn screening? Newborn screening is a set of three tests that check babies for serious, rare conditions.
More informationThere are four different forms of Tarui disease, which are classed by their signs and symptoms and age of presentation.
Tarui Disease Tarui disease (also known as phosphofructokinase deficiency, or glycogen storage disease type VII) was first described in 1965 by the Japanese physician Seiichiro Tarui and his co-workers.
More informationList of Chapters. 5. Care of the sick child Evidence-based pediatrics (page 77 to 80)
Illustrated Textbook of Paediatrics, 4th Edition Tom Lissauer, and Graham Clayden, 2012 List of Chapters 1. The child in society 2. History and examination 3. Normal child development, hearing and vision
More informationPAGE 1 NEURO-OPHTHALMIC QUESTIONNAIRE NAME: AGE: DATE OF EXAM: CHART #: (Office Use Only)
PAGE 1 NEURO-OPHTHALMIC QUESTIONNAIRE NAME: AGE: DATE OF EXAM: CHART #: (Office Use Only) 1. What is the main problem that you are having? (If additional space is required, please use the back of this
More informationIntroduction to Evaluating Hereditary Risk. Mollie Hutton, MS, CGC Certified Genetic Counselor Roswell Park Comprehensive Cancer Center
Introduction to Evaluating Hereditary Risk Mollie Hutton, MS, CGC Certified Genetic Counselor Roswell Park Comprehensive Cancer Center Objectives Describe genetic counseling and risk assessment Understand
More informationPatient Name: DOB: Age: Sex: Male Female Height: Weight: Dominant Hand: Right Left HISTORY OF PRESENT ILLNESS
CAPS PAINCARE Page 1 of 5 Today s : / / SSN (last 4 digits): xxx-xx - Patient Name: DOB: Age: Sex: Male Female Height: Weight: Dominant Hand: Right Left Type of Accident/Injury: Auto Work Personal Injury
More informationResult Navigator. Positive Test Result: PTEN. After a positive test result, there can be many questions about what to do next. Navigate Your Results
Result Navigator Positive Test Result: PTEN Positive test results identify a change, or misspelling, of DNA that is known or predicted to cause an increased risk for cancer. DNA is the blueprint of life
More informationGenetic Conditions and Services: An Introduction
Genetic Conditions and Services: An Introduction Jennifer Roberts, MC, MS, CGC Laboratory Genetics Counselor The Children s Mercy Hospital, 2017 Goals Determine which children/families may benefit from
More informationPrecision Medicine and Genetic Counseling : Is Yes always the correct answer?
Precision Medicine and Genetic Counseling : Is Yes always the correct answer? Beverly M. Yashar, MS, PhD, CGC Director, Graduate Program in Genetic Counseling Professor, Department of Human Genetics. (yashar@umich.edu)
More informationPrivigen solution for infusion
Privigen solution for infusion Haematology Patient Information What is is Privigen? Privigen? Privigen belongs in a class of medicines called human normal immunoglobins. Immunoglobulins are also called
More informationCenter for Advanced Wound Care New Patient Questionnaire Page 1 of 6
Center for Advanced Wound Care New Patient Questionnaire Page 1 of 6 These questions are general screening questions designed to identify areas where additional attention may be required. Please bring
More informationReproductive Technology, Genetic Testing, and Gene Therapy
Michael Cummings Chapter 16 Reproductive Technology, Genetic Testing, and Gene Therapy David Reisman University of South Carolina 16.1 Infertility Is a Common Problem In the US, about 13% of all couples
More informationAmy Powers (N) Michael Pryor
Newborn Screening Advisory Committee Meeting Meeting Minutes of Tuesday, October 13, 2015 12:00-3:00 Wilder Center Auditorium A - D 451 Lexington Parkway North Saint Paul, MN 55104 Committee Members Present:
More informationAmino Acid Disorders. Disorder name: Tyrosinemia, type 1. What is tyrosinemia 1? Genetic Fact Sheets for Parents
Genetic Fact Sheets for Parents Amino Acid Disorders Screening, Technology, and Research in Genetics is a multi-state project to improve information about the financial, ethical, legal, and social issues
More informationCURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE. Dr. Bahar Naghavi
2 CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE Dr. Bahar Naghavi Assistant professor of Basic Science Department, Shahid Beheshti University of Medical Sciences, Tehran,Iran 3 Introduction Over 4000
More informationIMAGING FINDINGS OF GAUCHER DISEASE IN ALL OVER THE BODY
IMAGING FINDINGS OF GAUCHER DISEASE IN ALL OVER THE BODY V. Katsaros 1, P. Lampropoulou 2, M. Mitropoulou 1, A. Nikolaou 1, C. Drossos 2 Departments of CT and MRI 1 IKA Oncology Hospital and 2 Athens General
More informationHeard About Genetic Counseling? What Does it Mean for You, Patients, and Families?
Heard About Genetic Counseling? What Does it Mean for You, Patients, and Families? Karin M. Dent, MS, LCGC Assistant Professor, Pediatrics Thursday, August 30 12:00-12:30pm Central Time Out for Genetics
More informationWiskott-Aldrich Syndrome
chapter 7 Wiskott-Aldrich Syndrome Wiskott-Aldrich syndrome is a primary immunodeficiency disease involving both T- and B-lymphocytes. In addition, the blood cells that help control bleeding, called platelets
More informationHurler Syndrome (Severe Type) -A Rare Case Report
Annals of Dental Research (2012) Vol 2 (1): 26-30 Mind Reader Publications: All Rights Reserved Annals of Dental Research www.adres.yolasite.com Case Report Hurler Syndrome (Severe Type) -A Rare Case Report
More informationAn Introduction to mitochondrial disease.
9 th September 2017 An Introduction to mitochondrial disease. Dr Andy Schaefer Consultant Neurologist and Clinical Lead NHS Highly Specialised Rare Mitochondrial Disease Service and Wellcome Trust Centre
More informationTEXAS VASCULAR ASSOCIATES, P.A. PATIENT CLINICAL INTAKE FORM
TEXAS VASCULAR ASSOCIATES, P.A. PATIENT CLINICAL INTAKE FORM PATIENT NAME: DATE OF BIRTH: TVA Physician being seen: Date of Visit: PAST MEDICAL HISTORY HEART PROBLEMS NEUROLOGICAL Congestive Heart Failure
More informationShould Universal Carrier Screening be Universal?
Should Universal Carrier Screening be Universal? Disclosures Research funding from Natera Mary E Norton MD University of California, San Francisco Antepartum and Intrapartum Management June 15, 2017 Burden
More informationDisclosures. Newborn Screening for Severe Combined Immune Deficiency Syndromes (SCIDS): Why; why now? Learning objectives.
Newborn Screening for Severe Combined Immune Deficiency Syndromes (SCIDS): Why; why now? Anthony J. Infante, MD, PhD Professor, Pediatrics and Microbiology & Immunology Chief, Division of Immunology &
More informationGenetic screening. Martin Delatycki
7 Genetic screening Martin Delatycki Case study 1 Vanessa and John are planning a family. They see their general practitioner and ask whether they should have any tests prior to falling pregnant to maximise
More informationSolution Title: CONGENITAL HEART DISEASE SCREENING IN THE NEWBORN
Institutional Affiliation: ANNE ARUNDEL MEDICAL CENTER Solution Title: CONGENITAL HEART DISEASE SCREENING IN THE NEWBORN Program/Project Description Congenital heart defects in general, and newborn screening
More informationAppropriate Use Criteria for Initial Transthoracic Echocardiography in Outpatient Pediatric Cardiology (scores listed by Appropriate Use rating)
Appropriate Use Criteria for Initial Transthoracic Echocardiography in Outpatient Pediatric Cardiology (scores listed by Appropriate Use rating) Table 1: Appropriate indications (median score 7-9) Indication
More informationSecretary's Advisory Committee on Heritable Disorders in Newborns and Children May 13, 2009
Secretary's Advisory Committee on Heritable Disorders in Newborns and Children May 13, 2009 R. Rodney Howell Genetic Alliance Posted in the Resource Repository at: http://www.resourcerepository.org/documents/658/secretary'sadvisorycommitteeonh
More informationMedical Advisory Council: Verified
What is White Sutton Syndrome? White Sutton Syndrome (WHSUS) is a condition characterized by autism and developmental delay and/or intellectual disability, as well as a characteristic facial profile. Children
More informationMax G. Bronstein Senior Director, Advocacy & Science Policy NEWBORN SCREENING WEBINAR
Max G. Bronstein mbronstein@everylifefoundation.org Senior Director, Advocacy & Science Policy NEWBORN SCREENING WEBINAR 1 Newborn Screening is not New First screen developed: test for phenylketonuria
More informationMedication Policy Manual. Topic: Fabrazyme, agalsidase beta Date of Origin: February 17, 2015
Medication Policy Manual Policy No: dru391 Topic: Fabrazyme, agalsidase beta Date of Origin: February 17, 2015 Committee Approval Date: March 13, 2015 Next Review Date: March 2016 Effective Date: July
More informationMetabolic Disorders Screened Overseas but not Screened in Australia Condition Features Inherited Diagnosis Treatment Newborn Screen
Metabolic Disorders ed Overseas but not ed in Australia Biotinidase Deficiency Severe form causes seizures & delay Biotin can prevent complications NZ, USA Tyrosinaemia Type I Coma & death before age 10
More informationOrganic Acid Disorders
Genetic Fact Sheets for Parents Organic Acid Disorders Screening, Technology, and Research in Genetics is a multi-state project to improve information about the financial, ethical, legal, and social issues
More informationCongenital Haemoglobinopathies
Congenital Haemoglobinopathies L. DEDEKEN, MD H O P I T A L U N I V E R S I T A I R E D E S E N F A N T S R E I N E F A B I O L A U N I V E R S I T E L I B R E DE B R U X E L L E S Red Blood Cell Disorders
More informationthorough physical and laboratory investigations fail to define the etiology of hearing loss. (2000, p. 16). In a report produced for the Maternal and
GUIDELINES FOR GENETIC EVALUATON REFERRAL The prevalence of permanent hearing loss in infants is estimated to be 2-3/1000 in the United States (Finitzo et al., 1998; Prieve et al., 2000). One or both ears
More informationNewborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis)
Newborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis) 1) Argininosuccinic acidemia (ASA) a) Incidence: ~1 in 70,000 b) Deficiency in an enzyme of
More informationCommunity Acquired Pneumonia
April 2014 References: 1. Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, Kaplan SL Mace SE, McCracken Jr. GH, Moor MR, St. Peter SD, Stockwell JA, and Swanson JT. The Management of
More information